There has been a great deal of discussion about the use of adjuvants to improve the immunogenicity of vaccines against the 2009 H1N1 pandemic influenza strain. What effect do these compounds have on the immune response? Adjuvants are compounds added to vaccines that stimulate the immune response. They are often used when the antigen is …
Hosts: Vincent Racaniello and Dick Despommier On episode #47 of the podcast “This Week in Virology”, Vincent and Dick discuss influenza virus-like particle vaccines produced in insect and plant cells, rapid sharing of influenza research, and answer listener questions about cytomegalovirus, viral evolution and symbiosis and much more. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV047.mp3″] Click the arrow above to …
Two different influenza vaccines will be available in the fall of 2009. One will be a trivalent preparation comprising seasonal influenza H3N2 and H1N1 strains, plus an influenza B virus strain. A monovalent vaccine will also be available against the 2009 pandemic H1N1 strain. Many readers of virology blog have asked why these four virus …
A new type of vaccine against influenza, made with virus-like particles, has been shown to protect ferrets from infection with the 2009 H1N1 swine-origin strain. What is a virus-like particle, and how is it produced? If you have been taking influenza 101, you know that new virus particles are produced in infected cells by budding. During …
Hosts: Vincent Racaniello, Dick Despommier, Alan Dove, and Jennifer Drahos In episode #44 of the podcast “This Week in Virology”, Vincent, Dick, Alan, and Jennifer Drahos consider Marburg virus in Egyptian fruit bats, bacterial citrus pathogen found in shipping facility, canine parvovirus in Michigan, Relenza-resistant influenza virus, new HIV from gorillas, and public engagement on …
The Centers for Disease Control and Prevention (CDC) would like to know what the public feels about the impending H1N1 influenza vaccination program this fall. The agency plans to conduct ten meetings in different parts of the United States to learn if the public would like a massive vaccination campaign, or a reduced effort. The meetings …
CDC wants the public to comment on H1N1 vaccination Read More »
